Building Consensus in Nonmelanoma Skin Cancer Care: Applying Emerging Science and Best Practices Authors: Axel Hauschild, MD; David M. Miller, MD, PhD; Vishal Anil Patel, MD; Marlies Wakkee, MD, PhD

https://www.medscape.org/viewarticle/building-consensus-nonmelanoma-skin-cancer-care-applying-2025a1000upd?page=1&sso=true&uac=148436CN&src=mkmcmr_driv_il_mscpedu_251231-12096431_ES_HONC#transcript-download-es

Genetic Variants May Thwart Monoclonal Antibody Binding Richard Mark Kirkner December 31, 2025

https://www.medscape.com/viewarticle/genetic-variants-may-thwart-monoclonal-antibody-binding-2025a10010s6

What’s the Time Burden of Women’s Cancers-Related Tasks? Edited by Gargi Mukherjee December 31, 2025

https://www.medscape.com/viewarticle/whats-time-burden-womens-cancers-related-tasks-2025a10010tl

Mastering Oral Therapies in CLL and MCL: Essential Strategies and Insights for Nurses Authors: Amy L. Goodrich, RN, MSN, CRNP-AC; Claudia Boglione, RN; Natacha Bolanos

https://www.medscape.org/viewarticle/mastering-oral-therapies-cll-and-mcl-essential-strategies-2025a1000xko?page=1&sso=true&uac=148436CN&src=mkmcmr_driv_il_mscpedu_251231-12116115_ES_HONC#transcript-download-es

Rapid Review Quiz: Artificial Sweeteners Reviewed by John Birk, MD October 07, 2025

https://reference.medscape.com/viewarticle/rapid-review-quiz-artificial-sweeteners-2025a1000p26?ecd=WNL_rrq_260101_MSCPEDIT_etid7995391&uac=148436CN&impID=7995391 Artificial Sweeteners Which of these is most accurate regarding the link between artificial sweetener intake and cardiovascular disease (CVD)? A. No association after adjustment for confounders B. Only individuals with obesity (BMI ≥ 30) were at increased risk C. Every teaspoon increase was associated with a modestly increased risk of incident CVD D. A significant reduction in CVD risk was associated with artificial sweetener use in individuals without diabetes

Student Behaving Strangely, Falls in a Breast-Cancer Patient, Rash in Inflammatory Disease +++ +...

Former Top Student Now Failing and Behaving Strangely Anne McBride, MD; Glen Xiong, MD https://reference.medscape.com/viewarticle/former-top-student-now-failing-and-behaving-strangely-2025a1000zuf?ecd=mkm_ret_260101_mscpmrk-OUS_DisReferences_etid7995393&uac=148436CN&impID=7995393 December 28, 2025 Falls and Fatigue in a Woman With Breast Cancer Camille F. Stanback, MD https://reference.medscape.com/viewarticle/falls-and-fatigue-woman-breast-cancer-2025a1000zp8?ecd=mkm_ret_260101_mscpmrk-OUS_DisReferences_etid7995393&uac=148436CN&impID=7995393 December 23, 2025 Pruritic Rash in a Woman With Chronic Inflammatory Disease Nathan C. Schedler; Steven R. Feldman, PhD, MD https://reference.medscape.com/viewarticle/pruritic-rash-woman-chronic-inflammatory-disease-2025a1000ytq?ecd=mkm_ret_260101_mscpmrk-OUS_DisReferences_etid7995393&uac=148436CN&impID=7995393 December 24, 2025 Calculators: Equations, Scores, and Dosage Formulas https://reference.medscape.com/guide/medical-calculators?ecd=mkm_ret_260101_mscpmrk-OUS_DisReferences_etid7995393&uac=148436CN&impID=7995393

Medscape AI : What Should I Know About Sexual Side Effects of GLP-1 Agonists? +++ (Medscape AI)

Medscape AI What Should I Know About Sexual Side Effects of GLP-1 Agonists? https://www.medscape.com/ai-search?query=What%20should%20I%20know%20about%20sexual%20side%20effects%20of%20GLP-1%20agonists%3F&&ecd=mkm_ret_260101_mscpmrk-OUS_DisReferences_etid7995393&uac=148436CN&impID=7995393 GLP-1 receptor agonists (RAs) have been associated with variable effects on sexual function, including both improvements and impairments in libido, arousal, and satisfaction. Clinicians should be aware of the following: What's New About Progestin in Contraceptives and Breast Cancer Risk? https://www.medscape.com/ai-search?query=What%27s%20new%20about%20progestin%20in%20contraceptives%20and%20breast%20cancer%20risk%3F&&ecd=mkm_ret_260101_mscpmrk-OUS_DisReferences_etid7995393&uac=148436CN&impID=7995393 Recent data highlight that progestin-containing contraceptives—both combined estrogen–progestin and progestin-only formulations—carry a modestly increased breast cancer risk, with variation by progestin type and duration of use. How Can I Differentiate Ordinary Daily Stress From an Underlying Mental Health Condition in a Patient? https://www.medscape.com/ai-search?query=How%20can%20I%20differentiate%20ordinary%20daily%20stress%20from%20an%20underlying%20mental%20health%20condition%20in%20a%20patient%3F&&ecd=mkm_ret_260101_mscpmrk-OUS_DisReferences_etid7995393&uac=148436CN&impID=7995393 Differentiating transient, situational stress from a diagnosable psychiatric disorder hinges on eliciting symptom quality, duration, functional impact, and congruence with established diagnostic criteria.